Company registration number 09939060 (England and Wales)
BRIGHTSTART DAY NURSERY GROUP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
BRIGHTSTART DAY NURSERY GROUP LIMITED
COMPANY INFORMATION
Directors
Mr C Barratt
Mrs D Barratt
Company number
09939060
Registered office
Sterling House
501 Middleton Road
Chadderton
Oldham
England
OL9 9LY
Auditor
BK Plus Audit Limited
Sterling House
501 Middleton Road
Chadderton
Oldham
Lancashire
OL9 9LY
BRIGHTSTART DAY NURSERY GROUP LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2 - 3
Independent auditor's report
4 - 6
Group statement of comprehensive income
7
Group balance sheet
8
Company balance sheet
9
Group statement of changes in equity
10
Company statement of changes in equity
11
Group statement of cash flows
12
Notes to the financial statements
13 - 29
BRIGHTSTART DAY NURSERY GROUP LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 1 -
The directors present the strategic report for the year ended 31 August 2025.
Principal activities
The principal activity of the parent company is that of a head office. The principal activities of the group is the provision of child daycare services.
Review of the business
The parent company has focused on further consolidation of its acquisitions whilst at the same time identifying other potential operations/businesses which are suitable for acquisition. It continues its strategy of investment in capital equipment, systems and staff that facilitate the groups key objective of providing high quality childcare.
Principal risks and uncertainties
Management continually monitors the key risks facing the group together with assessing the control used for managing these risks.
The principal risk identified is the magnitude of disruption from the inflationary pressures seen in the UK. As a consequence, the continuing hikes in staff and operational costs can prove challenging.
Development and performance
The market climate remains very competitive. The group continues to look for further strategic acquisitions that will complement its existing operations. It also continues to recognise the importance of providing high quality childcare at competitive prices.
Key performance indicators
The key performance indicators of our business are:
Mr C Barratt
Director
14 January 2026
BRIGHTSTART DAY NURSERY GROUP LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 AUGUST 2025
- 2 -
The directors present their annual report and financial statements for the year ended 31 August 2025.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £280,800. The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr C Barratt
Mrs D Barratt
The following also served as a director in all subsidiary companies:
Mr M Pilkington
Disabled persons
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the group continues and that the appropriate training is arranged. It is the policy of the group that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.
Employee involvement
Regular meetings are held between local management and employees to allow a free flow of information and ideas and to provide details of occupancy levels and customer feedback as appropriate.
Changes in presentation of the financial statements
This report has been prepared in accordance with the provisions applicable to groups and companies entitled to the exemptions of the small companies regime.
Auditor
The auditor, BK Plus Audit Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Statement of directors' responsibilities
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
United Kingdom company law requires the directors to prepare financial statements for each financial year. Under that law, the directors have elected to prepare the group and parent company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and parent company, and of the profit or loss of the group for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and parent company will continue in business.
BRIGHTSTART DAY NURSERY GROUP LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 3 -
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and parent company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and parent company, and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and parent company, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Strategic report
The truegroup has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of the business review, the principal risks and uncertainties, and future developments.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
Medium-sized companies exemption
This report has been prepared in accordance with the provisions applicable to groups and companies entitled to the exemptions of the small companies regime.
On behalf of the board
Mr C Barratt
Director
14 January 2026
BRIGHTSTART DAY NURSERY GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BRIGHTSTART DAY NURSERY GROUP LIMITED
- 4 -
Opinion
We have audited the financial statements of Brightstart Day Nursery Group Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 August 2025 which comprise the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 August 2025 and of the group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
BRIGHTSTART DAY NURSERY GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF BRIGHTSTART DAY NURSERY GROUP LIMITED
- 5 -
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the group's and parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or parent company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.
Based on our understanding of the company, we identified that the principal risks of non-compliance related to those laws and regulations that have a direct impact on the financial statements such as the Companies Act 2006 and FRS 102. We evaluated managements incentives and opportunities for fraudulent manipulation of the financial statements (including the risk of override of controls), and determined that the principal risks were related to posting inappropriate journal entries to manipulate financial results and management bias in accounting estimates. Appropriate audit procedures were therefore performed to address those risks including testing journal entries and challenging assumptions and judgements made by management in their significant accounting estimates. There are inherent limitations in the audit procedures described above and the further removed non compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. Also the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example forgery or intentional misrepresentations, or through collusion.
BRIGHTSTART DAY NURSERY GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF BRIGHTSTART DAY NURSERY GROUP LIMITED
- 6 -
As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:
Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
Obtain an understanding of internal control relevant to the audit in order to design audit
procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the group's internal control.
Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the directors.
Conclude on the appropriateness of the directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the group's or the parent company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the group or the parent company to cease to continue as a going concern.
Evaluate the overall presentation, structure and content of the financial statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that achieves fair presentation.
Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision and performance of the group audit. We remain solely responsible for our audit opinion.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
Dominic Huxley ACA (Senior Statutory Auditor)
For and on behalf of BK Plus Audit Limited, Statutory Auditor
Chartered Certified Accountants
Sterling House
501 Middleton Road
Chadderton
Oldham
Lancashire
OL9 9LY
14 January 2026
BRIGHTSTART DAY NURSERY GROUP LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 AUGUST 2025
- 7 -
2025
2024
Notes
£
£
Turnover
3
8,538,781
6,692,244
Cost of sales
(396,751)
(331,522)
Gross profit
8,142,030
6,360,722
Administrative expenses
(6,484,707)
(5,315,156)
Other operating income
118,333
24,583
Operating profit
4
1,775,656
1,070,149
Interest receivable and similar income
7
182,985
68,024
Interest payable and similar expenses
8
(194,551)
(229,044)
Profit before taxation
1,764,090
909,129
Tax on profit
9
(468,950)
(241,116)
Profit for the financial year
25
1,295,140
668,013
Profit for the financial year is all attributable to the owners of the parent company.
Total comprehensive income for the year is all attributable to the owners of the parent company.
BRIGHTSTART DAY NURSERY GROUP LIMITED
GROUP BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 8 -
2025
2024
Notes
£
£
£
£
Fixed assets
Goodwill
11
439,366
506,105
Total intangible assets
439,366
506,105
Tangible assets
12
5,584,446
5,269,989
6,023,812
5,776,094
Current assets
Stocks
15
6,502
6,273
Debtors
16
23,994
50,248
Cash at bank and in hand
5,299,575
4,046,079
5,330,071
4,102,600
Creditors: amounts falling due within one year
17
(2,547,224)
(1,688,331)
Net current assets
2,782,847
2,414,269
Total assets less current liabilities
8,806,659
8,190,363
Creditors: amounts falling due after more than one year
18
(5,290,065)
(5,722,474)
Provisions for liabilities
Deferred tax liability
21
150,016
115,651
(150,016)
(115,651)
Net assets
3,366,578
2,352,238
Capital and reserves
Called up share capital
24
8
8
Revaluation reserve
25
236,221
236,221
Profit and loss reserves
25
3,130,349
2,116,009
Total equity
3,366,578
2,352,238
These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.
The financial statements were approved by the board of directors and authorised for issue on 14 January 2026 and are signed on its behalf by:
14 January 2026
Mr C Barratt
Director
Company registration number 09939060 (England and Wales)
BRIGHTSTART DAY NURSERY GROUP LIMITED
COMPANY BALANCE SHEET
AS AT 31 AUGUST 2025
31 August 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
12
5,107,564
5,063,974
Investments
13
714,873
714,873
5,822,437
5,778,847
Current assets
Debtors
16
318,148
28,235
Cash at bank and in hand
2,542,832
2,614,242
2,860,980
2,642,477
Creditors: amounts falling due within one year
17
(568,662)
(553,578)
Net current assets
2,292,318
2,088,899
Total assets less current liabilities
8,114,755
7,867,746
Creditors: amounts falling due after more than one year
18
(5,290,065)
(5,722,474)
Provisions for liabilities
Deferred tax liability
21
71,887
77,291
(71,887)
(77,291)
Net assets
2,752,803
2,067,981
Capital and reserves
Called up share capital
24
8
8
Revaluation reserve
25
236,221
236,221
Profit and loss reserves
25
2,516,574
1,831,752
Total equity
2,752,803
2,067,981
As permitted by section 408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £965,622 (2024 - £645,112 profit).
These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 14 January 2026 and are signed on its behalf by:
14 January 2026
Mr C Barratt
Director
Company registration number 09939060 (England and Wales)
BRIGHTSTART DAY NURSERY GROUP LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2025
- 10 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 September 2023
8
236,221
1,728,796
1,965,025
Year ended 31 August 2024:
Profit and total comprehensive income
-
-
668,013
668,013
Dividends
10
-
-
(280,800)
(280,800)
Balance at 31 August 2024
8
236,221
2,116,009
2,352,238
Year ended 31 August 2025:
Profit and total comprehensive income
-
-
1,295,140
1,295,140
Dividends
10
-
-
(280,800)
(280,800)
Balance at 31 August 2025
8
236,221
3,130,349
3,366,578
BRIGHTSTART DAY NURSERY GROUP LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 AUGUST 2025
- 11 -
Share capital
Revaluation reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 September 2023
8
236,221
1,467,440
1,703,669
Year ended 31 August 2024:
Profit and total comprehensive income for the year
-
-
645,112
645,112
Dividends
10
-
-
(280,800)
(280,800)
Balance at 31 August 2024
8
236,221
1,831,752
2,067,981
Year ended 31 August 2025:
Profit and total comprehensive income
-
-
965,622
965,622
Dividends
10
-
-
(280,800)
(280,800)
Balance at 31 August 2025
8
236,221
2,516,574
2,752,803
BRIGHTSTART DAY NURSERY GROUP LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 AUGUST 2025
- 12 -
2025
2024
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
27
2,565,432
2,024,136
Interest paid
(194,551)
(229,044)
Income taxes paid
(178,393)
(275,669)
Net cash inflow from operating activities
2,192,488
1,519,423
Investing activities
Purchase of tangible fixed assets
(439,868)
(78,982)
Proceeds from disposal of tangible fixed assets
12,100
-
Interest received
182,985
68,024
Net cash used in investing activities
(244,783)
(10,958)
Financing activities
Repayment of bank loans
(407,589)
(398,402)
Payment of finance leases obligations
(5,820)
(5,820)
Dividends paid to equity shareholders
(280,800)
(280,800)
Net cash used in financing activities
(694,209)
(685,022)
Net increase in cash and cash equivalents
1,253,496
823,443
Cash and cash equivalents at beginning of year
4,046,079
3,222,637
Cash and cash equivalents at end of year
5,299,575
4,046,079
CASH FLOW OUT OF BALANCE BY:
-
1
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2025
- 13 -
1
Accounting policies
Company information
Brightstart Day Nursery Group Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Sterling House, 501 Middleton Road, Chadderton, Oldham, England, OL9 9LY.
The group consists of Brightstart Day Nursery Group Limited and all of its subsidiaries.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 26 ‘Share based Payment’: Share-based payment expense charged to profit or loss, reconciliation of opening and closing number and weighted average exercise price of share options, how the fair value of options granted was measured, measurement and carrying amount of liabilities for cash-settled share-based payments, explanation of modifications to arrangements;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 14 -
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Brightstart Day Nursery Group Limited together with all entities controlled by the parent company (its subsidiaries) and the group’s share of its interests in joint ventures and associates.
All financial statements are made up to 31 August 2025. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
1.4
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the group and parent company have adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.5
Turnover
Turnover for the parent is derived from its principal activity of commercial property renting and represents amounts receivable in respect of rents due from subsidiary companies, such turnover recognised in respect of the periods of occupation and associated commercial lease agreements.
Turnover is recognised when the economic benefits of occupation have been transferred to the subsidiary company.
Turnover for the subsidiaries is measured at fair value of the fees receivable for the provision of childcare during the year. Turnover is recognised when these services are provided.
1.6
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of a business over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 5-10years.
For the purposes of impairment testing, goodwill is allocated to the cash-generating units expected to benefit from the acquisition. Cash-generating units to which goodwill has been allocated are tested for impairment at least annually, or more frequently when there is an indication that the unit may be impaired. If the recoverable amount of the cash-generating unit is less than the carrying amount of the unit, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then to the other assets of the unit pro-rata on the basis of the carrying amount of each asset in the unit.
1.7
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 15 -
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
2% straight line
Leasehold land and buildings
2% straight line
Fixtures and fittings
20% straight line
Motor vehicles
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
In the director's opinion the residual value of the freehold and leasehold property is greater than cost so no depreciation charge is recognised in the financial statements.
1.8
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The group considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Investments in associates are initially recognised at the transaction price (including transaction costs) and are subsequently adjusted to reflect the group’s share of the profit or loss, other comprehensive income and equity of the associate using the equity method. Any difference between the cost of acquisition and the share of the fair value of the net identifiable assets of the associate on acquisition is recognised as goodwill. Any unamortised balance of goodwill is included in the carrying value of the investment in associates.
Losses in excess of the carrying amount of an investment in an associate are recorded as a provision only when the company has incurred legal or constructive obligations or has made payments on behalf of the associate.
In the parent company financial statements, investments in associates are accounted for at cost less impairment.
Entities in which the group has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 16 -
1.9
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
The carrying amount of the investments accounted for using the equity method is tested for impairment as a single asset. Any goodwill included in the carrying amount of the investment is not tested separately for impairment.
Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.
If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.
Recognised impairment losses are reversed if, and only if, the reasons for the impairment loss have ceased to apply. Where an impairment loss subsequently reverses, the carrying amount of the asset (or cash-generating unit) is increased to the revised estimate of its recoverable amount, but so that the increased carrying amount does not exceed the carrying amount that would have been determined had no impairment loss been recognised for the asset (or cash-generating unit) in prior years. A reversal of an impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the reversal of the impairment loss is treated as a revaluation increase.
1.10
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.
1.11
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.12
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 17 -
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
Other financial assets
Other financial assets, including investments in equity instruments which are not subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the transaction price. Such assets are subsequently carried at fair value and the changes in fair value are recognised in profit or loss, except that investments in equity instruments that are not publicly traded and whose fair values cannot be measured reliably are measured at cost less impairment.
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 18 -
Other financial liabilities
Derivatives, including interest rate swaps and forward foreign exchange contracts, are not basic financial instruments. Derivatives are initially recognised at fair value on the date a derivative contract is entered into and are subsequently re-measured at their fair value. Changes in the fair value of derivatives are recognised in profit or loss in finance costs or finance income as appropriate, unless hedge accounting is applied and the hedge is a cash flow hedge.
Debt instruments that do not meet the conditions in FRS 102 paragraph 11.9 are subsequently measured at fair value through profit or loss. Debt instruments may be designated as being measured at fair value through profit or loss to eliminate or reduce an accounting mismatch or if the instruments are measured and their performance evaluated on a fair value basis in accordance with a documented risk management or investment strategy.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.13
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.14
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
1.15
Provisions
Provisions are recognised when the group has a legal or constructive present obligation as a result of a past event, it is probable that the group will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.
The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
1
Accounting policies
(Continued)
- 19 -
1.16
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.17
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.18
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.
Rental income from operating leases is recognised on a straight line basis over the term of the relevant lease. Initial direct costs incurred in negotiating and arranging an operating lease are added to the carrying amount of the leased asset and recognised on a straight line basis over the lease term.
1.19
Government grants
Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received.
A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.
1.20
Exceptional items are disclosed separately in the financial statements in order to provide further understanding of the financial performance of the entity. They are material items of income or expense that have been shown separately because of their nature or amount.
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 20 -
2
Judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
In the opinion of the directors there are no significant accounting judgements relevant to the application of these policies.
3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Rendering of services
8,538,781
6,692,244
2025
2024
£
£
Other revenue
Interest income
182,985
68,024
Grants received
35,000
-
The whole of the turnover is attributable to the principal activity of the group wholly undertaken in the United Kingdom.
4
Operating profit
2025
2024
£
£
Operating profit for the year is stated after charging/(crediting):
Government grants
(35,000)
-
Fees payable to the group's auditor for the audit of the group's financial statements
8,400
6,120
Depreciation of tangible fixed assets
112,119
116,863
Loss on disposal of tangible fixed assets
1,192
-
Amortisation of intangible assets
66,739
66,739
Operating lease charges
8,230
8,230
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 21 -
5
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2025
2024
2025
2024
Number
Number
Number
Number
Administrative staff
249
247
-
-
Management staff
5
5
5
5
Total
254
252
5
5
Their aggregate remuneration comprised:
Group
Company
2025
2024
2025
2024
£
£
£
£
Wages and salaries
4,658,784
4,008,372
290,480
214,523
Social security costs
412,016
258,427
40,776
27,886
Pension costs
388,545
143,469
316,319
84,499
5,459,345
4,410,268
647,575
326,908
6
Directors' remuneration
2025
2024
£
£
Company pension contributions to defined contribution schemes
260,000
60,000
7
Interest receivable and similar income
2025
2024
£
£
Interest income
Interest on bank deposits
172,726
68,386
Other interest income
10,259
(362)
Total income
182,985
68,024
8
Interest payable and similar expenses
2025
2024
£
£
Interest on finance leases and hire purchase contracts
1,044
1,044
Other interest
193,507
228,000
Total finance costs
194,551
229,044
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 22 -
9
Taxation
2025
2024
£
£
Current tax
UK corporation tax on profits for the current period
429,890
252,005
Adjustments in respect of prior periods
4,695
Total current tax
434,585
252,005
Deferred tax
Origination and reversal of timing differences
34,365
(10,889)
Total tax charge
468,950
241,116
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2025
2024
£
£
Profit before taxation
1,764,090
909,129
Expected tax charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
441,023
227,282
Tax effect of expenses that are not deductible in determining taxable profit
2,254
Tax effect of income not taxable in determining taxable profit
(6,146)
Adjustments in respect of prior years
4,695
Effect of change in corporation tax rate
-
19
Group relief
(19)
Other non-reversing timing differences
(2,972)
Effect of capital allowances and depreciation
20,978
22,952
Taxation charge
468,950
241,116
10
Dividends
2025
2024
Recognised as distributions to equity holders:
£
£
Final paid
280,800
-
Interim paid
-
280,800
280,800
280,800
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 23 -
11
Intangible fixed assets
Group
Goodwill
£
Cost
At 1 September 2024 and 31 August 2025
4,055,810
Amortisation and impairment
At 1 September 2024
3,549,705
Amortisation charged for the year
66,739
At 31 August 2025
3,616,444
Carrying amount
At 31 August 2025
439,366
At 31 August 2024
506,105
The company had no intangible fixed assets at 31 August 2025 or 31 August 2024.
12
Tangible fixed assets
Group
Freehold land and buildings
Leasehold land and buildings
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost or valuation
At 1 September 2024
4,270,814
708,316
1,004,603
116,602
6,100,335
Additions
302,350
50,160
87,358
439,868
Disposals
(14,500)
(14,500)
At 31 August 2025
4,270,814
1,010,666
1,054,763
189,460
6,525,703
Depreciation and impairment
At 1 September 2024
797,433
32,913
830,346
Depreciation charged in the year
82,267
29,852
112,119
Eliminated in respect of disposals
(1,208)
(1,208)
At 31 August 2025
879,700
61,557
941,257
Carrying amount
At 31 August 2025
4,270,814
1,010,666
175,063
127,903
5,584,446
At 31 August 2024
4,270,814
708,316
207,170
83,689
5,269,989
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
12
Tangible fixed assets
(Continued)
- 24 -
Company
Freehold land and buildings
Leasehold land and buildings
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost or valuation
At 1 September 2024
4,270,814
708,316
9,986
116,602
5,105,718
Additions
87,358
87,358
Disposals
(14,500)
(14,500)
At 31 August 2025
4,270,814
708,316
9,986
189,460
5,178,576
Depreciation and impairment
At 1 September 2024
8,831
32,913
41,744
Depreciation charged in the year
624
29,852
30,476
Eliminated in respect of disposals
(1,208)
(1,208)
At 31 August 2025
9,455
61,557
71,012
Carrying amount
At 31 August 2025
4,270,814
708,316
531
127,903
5,107,564
At 31 August 2024
4,270,814
708,316
1,155
83,689
5,063,974
Freehold and leasehold property was professionally revalued on an open market basis by Colliers Chartered Surveyors on 26 April 2017, and included in the financial statements since 31 August 2017. A more recent valuation was carried out by Avison Young Estates Agents on 02 August 2021 on the same basis. The directors consider that the current residual value of freehold and leasehold property is equal to or greater than the market value included within the accounts. As a result no depreciation has been charged. The surplus on revaluation has been credited to the revaluation reserve, net of the potential tax liability that would arise if the property were to be sold at its revalued amount.
The following assets are carried at valuation. If the assets were measured using the cost model, the carrying amounts would be as follows:
Land and buildings
2025
2024
£
£
Group
Cost
4,966,518
4,664,168
Company
Cost
4,664,168
4,664,168
Carrying value
4,664,168
4,664,168
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 25 -
13
Fixed asset investments
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Investments in subsidiaries
14
714,873
714,873
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 September 2024 and 31 August 2025
714,873
Carrying amount
At 31 August 2025
714,873
At 31 August 2024
714,873
14
Subsidiaries
Details of the company's subsidiaries at 31 August 2025 are as follows:
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Happy Tots Day Nursery Limited
United Kingdom
Ordinary
100.00
Chrysalis Day Nursery Cheshire Limited
United Kingdom
Ordinary
100.00
Busy Bees (Durham) Limited
United Kingdom
Ordinary
100.00
Busy Bears (Durham) Limited
United Kingdom
Ordinary
100.00
First Steps Day Nursery and Pre-School Limited
United Kingdom
Ordinary
100.00
Emmy Jaynes Nursery School Limited
United Kingdom
Ordinary
100.00
15
Stocks
Group
Company
2025
2024
2025
2024
£
£
£
£
Raw materials and consumables
6,502
6,273
-
-
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 26 -
16
Debtors
Group
Company
2025
2024
2025
2024
Amounts falling due within one year:
£
£
£
£
Trade debtors
8,196
20,013
Amounts owed by group undertakings
302,350
Other debtors
15,798
27,798
15,798
25,798
Prepayments and accrued income
2,437
2,437
23,994
50,248
318,148
28,235
17
Creditors: amounts falling due within one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans
19
429,000
410,000
429,000
410,000
Obligations under finance leases
20
5,820
5,820
5,820
5,820
Corporation tax payable
429,890
173,698
370
Other taxation and social security
25,300
Deferred income
22
1,134,408
583,619
25,000
25,000
Other creditors
1
24,386
1
16,626
Accruals and deferred income
548,105
465,508
108,841
95,762
2,547,224
1,688,331
568,662
553,578
18
Creditors: amounts falling due after more than one year
Group
Company
2025
2024
2025
2024
Notes
£
£
£
£
Bank loans and overdrafts
19
5,282,789
5,709,378
5,282,789
5,709,378
Obligations under finance leases
20
7,276
13,096
7,276
13,096
5,290,065
5,722,474
5,290,065
5,722,474
19
Loans and overdrafts
Group
Company
2025
2024
2025
2024
£
£
£
£
Bank loans
5,711,789
6,119,378
5,711,789
6,119,378
Payable within one year
429,000
410,000
429,000
410,000
Payable after one year
5,282,789
5,709,378
5,282,789
5,709,378
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
19
Loans and overdrafts
(Continued)
- 27 -
The bank loans are secured by way of fixed and floating charges against all properties.
Included within creditors: amounts falling due after more than one year is an amount of £3,404,789 (2024: £3,931,378) for the group and £3,404,789 (2024: £3,931,378) for the company in respect of liabilities payable or repayable by instalments which fall due for payment after more than five years from the reporting date.
The group's financing facilities includes two bank loans of £5,259,756 and £452,033. The former accrues interest at a rate of 3.26% per annum for 9 years followed by 2.25% over base rate until the loan is repaid in full and the latter accrues interest at a rate of 3.26% per annum for the duration of the loan. Both loans are due for repayment in full in 2036.
20
Finance lease obligations
Group
Company
2025
2024
2025
2024
Amounts due:
£
£
£
£
Current liabilities
5,820
5,820
5,820
5,820
Non-current liabilities
7,276
13,096
7,276
13,096
13,096
18,916
13,096
18,916
Group
Company
2025
2024
2025
2024
£
£
£
£
Future minimum lease payments due under finance leases:
Within one year
5,820
5,820
5,820
5,820
In two to five years
7,276
13,096
7,276
13,096
13,096
18,916
13,096
18,916
21
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company, and movements thereon:
Liabilities
Liabilities
2025
2024
Group
£
£
Accelerated capital allowances
71,276
36,910
Revaluations
78,740
78,741
150,016
115,651
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
21
Deferred taxation
(Continued)
- 28 -
Liabilities
Liabilities
2025
2024
Company
£
£
Accelerated capital allowances
(6,853)
(1,450)
Revaluations
78,740
78,741
71,887
77,291
Group
Company
2025
2025
Movements in the year:
£
£
Liability at 1 September 2024
115,651
77,291
Charge/(credit) to profit or loss
34,365
(5,404)
Liability at 31 August 2025
150,016
71,887
22
Deferred income
Group
Company
2025
2024
2025
2024
£
£
£
£
Other deferred income
1,134,408
583,619
25,000
25,000
23
Retirement benefit schemes
2025
2024
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
388,545
143,469
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
24
Share capital
Group and company
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
8
8
8
8
BRIGHTSTART DAY NURSERY GROUP LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 AUGUST 2025
- 29 -
25
Reserves
Revaluation reserve
Revaluation reserve - This reserve records the value of asset revaluations and fair value movements on assets recognised in other comprehensive income.
Retained earnings
Profit and loss account - This reserve records retained earnings and accumulated losses.
26
Related party transactions
Within other debtors is an advance to Mr M Pilkington (director of subsidiary companies) amounting to £15,798 (2024: £25,798 ). Of this, £5,798 (2024: £15,798) is due after more than one year. Interest is payable on a commercial basis.
27
Cash generated from group operations
2025
2024
£
£
Profit after taxation
1,295,140
668,013
Adjustments for:
Taxation charged
468,950
241,116
Finance costs
194,551
229,044
Investment income
(182,985)
(68,024)
Loss on disposal of tangible fixed assets
1,192
-
Amortisation and impairment of intangible assets
66,739
66,739
Depreciation and impairment of tangible fixed assets
112,119
116,863
Movements in working capital:
(Increase)/decrease in stocks
(229)
305
Decrease in debtors
26,254
4,032
Increase in creditors
32,912
182,429
Increase in deferred income
550,789
583,619
Cash generated from operations
2,565,432
2,024,136
28
Analysis of changes in net debt - group
1 September 2024
Cash flows
31 August 2025
£
£
£
Cash at bank and in hand
4,046,079
1,253,496
5,299,575
Borrowings excluding overdrafts
(6,119,378)
407,589
(5,711,789)
Obligations under finance leases
(18,916)
5,820
(13,096)
(2,092,215)
1,666,905
(425,310)
2025-08-312024-09-01falsefalseCCH SoftwareCCH Accounts Production 2026.100Mr C BarrattMrs D Barrattfalse09939060bus:Consolidated2024-09-012025-08-31099390602024-09-012025-08-3109939060bus:Director12024-09-012025-08-3109939060bus:Director22024-09-012025-08-3109939060bus:RegisteredOffice2024-09-012025-08-31099390602025-08-3109939060bus:Consolidated2025-08-3109939060bus:Consolidated2023-09-012024-08-31099390602023-09-012024-08-3109939060core:Goodwillbus:Consolidated2025-08-3109939060core:Goodwillbus:Consolidated2024-08-3109939060bus:Consolidated2024-08-3109939060core:NetGoodwill2024-08-31099390602024-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2025-08-3109939060core:FurnitureFittingsbus:Consolidated2025-08-3109939060core:MotorVehiclesbus:Consolidated2025-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2024-08-3109939060core:FurnitureFittingsbus:Consolidated2024-08-3109939060core:MotorVehiclesbus:Consolidated2024-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssets2025-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLessee2025-08-3109939060core:FurnitureFittings2025-08-3109939060core:MotorVehicles2025-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-3109939060core:FurnitureFittings2024-08-3109939060core:MotorVehicles2024-08-3109939060core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-08-3109939060core:CurrentFinancialInstrumentsbus:Consolidated2024-08-3109939060core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2024-08-3109939060core:Non-currentFinancialInstrumentscore:AfterOneYear2025-08-3109939060core:Non-currentFinancialInstrumentscore:AfterOneYear2024-08-3109939060core:CurrentFinancialInstrumentscore:WithinOneYear2025-08-3109939060core:CurrentFinancialInstrumentscore:WithinOneYear2024-08-3109939060core:ShareCapitalbus:Consolidated2025-08-3109939060core:ShareCapitalbus:Consolidated2024-08-3109939060core:RevaluationReservebus:Consolidated2025-08-3109939060core:RevaluationReservebus:Consolidated2024-08-3109939060core:RetainedEarningsAccumulatedLossesbus:Consolidated2025-08-3109939060core:RetainedEarningsAccumulatedLossesbus:Consolidated2024-08-3109939060core:ShareCapital2025-08-3109939060core:ShareCapital2024-08-3109939060core:RevaluationReserve2025-08-3109939060core:RevaluationReserve2024-08-3109939060core:RetainedEarningsAccumulatedLosses2025-08-3109939060core:RetainedEarningsAccumulatedLosses2024-08-3109939060core:ShareCapitalbus:Consolidated2023-08-3109939060core:SharePremiumbus:Consolidated2023-08-31099390602023-08-3109939060core:ShareCapital2023-08-3109939060core:RevaluationReserve2023-08-3109939060core:RetainedEarningsAccumulatedLosses2023-08-3109939060bus:Consolidated2023-08-3109939060core:Goodwill2024-09-012025-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssets2024-09-012025-08-3109939060core:LandBuildingscore:LongLeaseholdAssets2024-09-012025-08-3109939060core:FurnitureFittings2024-09-012025-08-3109939060core:MotorVehicles2024-09-012025-08-3109939060core:UKTaxbus:Consolidated2024-09-012025-08-3109939060core:UKTaxbus:Consolidated2023-09-012024-08-3109939060bus:Consolidated12024-09-012025-08-3109939060bus:Consolidated12023-09-012024-08-3109939060core:Goodwillbus:Consolidated2024-08-3109939060core:Goodwillbus:Consolidated2024-09-012025-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2024-08-3109939060core:FurnitureFittingsbus:Consolidated2024-08-3109939060core:MotorVehiclesbus:Consolidated2024-08-3109939060bus:Consolidated2024-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssets2024-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-08-3109939060core:FurnitureFittings2024-08-3109939060core:MotorVehicles2024-08-31099390602024-08-3109939060core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2024-09-012025-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLesseebus:Consolidated2024-09-012025-08-3109939060core:FurnitureFittingsbus:Consolidated2024-09-012025-08-3109939060core:MotorVehiclesbus:Consolidated2024-09-012025-08-3109939060core:LandBuildingscore:LeasedAssetsHeldAsLessee2024-09-012025-08-3109939060core:Subsidiary12024-09-012025-08-3109939060core:Subsidiary22024-09-012025-08-3109939060core:Subsidiary32024-09-012025-08-3109939060core:Subsidiary42024-09-012025-08-3109939060core:Subsidiary52024-09-012025-08-3109939060core:Subsidiary62024-09-012025-08-3109939060core:Subsidiary112024-09-012025-08-3109939060core:Subsidiary222024-09-012025-08-3109939060core:Subsidiary332024-09-012025-08-3109939060core:Subsidiary442024-09-012025-08-3109939060core:Subsidiary552024-09-012025-08-3109939060core:Subsidiary662024-09-012025-08-3109939060core:CurrentFinancialInstrumentsbus:Consolidated2025-08-3109939060core:CurrentFinancialInstruments2025-08-3109939060core:CurrentFinancialInstruments2024-08-3109939060core:CurrentFinancialInstrumentsbus:Consolidated12025-08-3109939060core:CurrentFinancialInstrumentsbus:Consolidated12024-08-3109939060core:CurrentFinancialInstruments22025-08-3109939060core:CurrentFinancialInstruments22024-08-3109939060core:WithinOneYearbus:Consolidated2025-08-3109939060core:WithinOneYearbus:Consolidated2024-08-3109939060core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2025-08-3109939060core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2024-08-3109939060core:Non-currentFinancialInstrumentsbus:Consolidated2025-08-3109939060core:Non-currentFinancialInstrumentsbus:Consolidated2024-08-3109939060core:Non-currentFinancialInstruments2025-08-3109939060core:Non-currentFinancialInstruments2024-08-3109939060core:WithinOneYear2025-08-3109939060core:WithinOneYear2024-08-3109939060core:BetweenTwoFiveYearsbus:Consolidated2025-08-3109939060core:BetweenTwoFiveYearsbus:Consolidated2024-08-3109939060core:BetweenTwoFiveYears2025-08-3109939060core:BetweenTwoFiveYears2024-08-3109939060bus:PrivateLimitedCompanyLtd2024-09-012025-08-3109939060bus:FRS1022024-09-012025-08-3109939060bus:Audited2024-09-012025-08-3109939060bus:ConsolidatedGroupCompanyAccounts2024-09-012025-08-3109939060bus:FullAccounts2024-09-012025-08-31xbrli:purexbrli:sharesiso4217:GBP